CREATION OF A BIOLOGICALLY ACTIVE COMPOSITE, KNOWN AS FIBROFILL COMPLEX, FOR THE REGENERATION OF THE MUCOSA (Q2044181)
Jump to navigation
Jump to search
Project Q2044181 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CREATION OF A BIOLOGICALLY ACTIVE COMPOSITE, KNOWN AS FIBROFILL COMPLEX, FOR THE REGENERATION OF THE MUCOSA |
Project Q2044181 in Italy |
Statements
12,500.0 Euro
0 references
25,000.0 Euro
0 references
50.0 percent
0 references
30 January 2018
0 references
29 September 2018
0 references
BLAST RESEARCH S.R.L.
0 references
Q286227 (Deleted Item)
0 references
45°49'5.70"N, 8°49'36.84"E
0 references
IL PROGETTO HA LO SCOPO DI COMPLETARE GLI STUDI SU UN PRINCIPIO ATTIVO BIOLOGICO DI DERIVAZIONE UMANA DA UTILIZZARE IN COMBINAZIONE CON ACIDO IALURONICO, SFRUTTANDONE LE CAPACIT RIGENERATIVE - FIBROFILL COMPLEX . BASANDOSI SU QUESTO PRINCIPIO ATTIVO E PARTENDO DAL MECCANISMO DAZIONE DEL FARMACO FIBROFILL, GI VALIDATO DALLAGENZIA DEL FARMACO EUROPEA (EMA) E INTERAMENTE SVILUPPATO DA BLAST RESEARCH, LAZIENDA INTENDE REALIZZARE UN SISTEMA INNOVATIVO DI PRODOTTI PER LATTENUAZIONE DELLE IRRIT (Italian)
0 references
THE AIM OF THE PROJECT IS TO COMPLETE THE STUDIES ON A BIOLOGICAL ACTIVE INGREDIENT OF HUMAN ORIGIN TO BE USED IN COMBINATION WITH HYALURONIC ACID, TO BE EXPLOITED THROUGH ITS REGENERATIVE SOURCES, FIBROFILL COMPLEX. RELYING ON THIS ACTIVE INGREDIENT AND STARTING WITH THE ACTION MECHANISM OF THE MEDICINAL PRODUCT FIBROLFILL, GI VALIDATED BY THE EUROPEAN MEDICINES AGENCY (EMA) AND ENTIRELY DEVELOPED BY BELAST RESEARCH, LAZIOMAR INTENDS TO IMPLEMENT AN INNOVATIVE SYSTEM OF PRODUCTS FOR LATTENDERO DELLE IRRIT. (English)
0 references
Identifiers
E47H18000640007
0 references